BIT
RGNX icon

BlackRock Institutional Trust’s Regenxbio RGNX Stock Holding History

BlackRock Institutional Trust’s Portfolio RGNX Stock Details RGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$10.2M Buy
552,022
+243,617
+79% +$4.66M ﹤0.01% 2393
2016
Q3 		$4.32M Buy
308,405
+138,085
+81% +$1.52M ﹤0.01% 2751
2016
Q2 		$1.36M Buy
170,320
+111,499
+190% +$1.24M ﹤0.01% 3194
2016
Q1 		$635K Buy
58,821
+27,960
+91% +$358K ﹤0.01% 3400
2015
Q4 		$512K Buy
30,861
+30,055
+3,729% +$597K ﹤0.01% 3505
2015
Q3 		$18K Buy
+806
New +$20.6K ﹤0.01% 3897

Other funds holding RGNX

BCPEM
Bain Capital Public Equity Management Boston, Massachusetts $1.05B AUM 25.71% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BA
BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return